Skip to content

Efficacy of Lower Extremity Mirror Therapy on Balance in Children With Hemiplegic Cerebral Palsy

EFFICACY OF LOWER EXTREMITY MIRROR THERAPY ON BALANCE IN CHILDREN WITH HEMIPLEGIC CEREBRAL PALSY: A Randomized Controlled Trail

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04227262
Enrollment
70
Registered
2020-01-13
Start date
2019-12-01
Completion date
2020-03-31
Last updated
2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

HEMIPLEGIC CEREBRAL PALSY

Keywords

cerebral palsy, balance, mirror therapy

Brief summary

The study will be conducted to assess the efficacy of mirror therapy on balance in children with hemiplegic cerebral palsy.

Detailed description

Hemiplegic cerebral palsy in the most common type of cerebral palsy that has permanent motor disorders and associated with life-long disability. the aim of study to assess the efficacy of mirror therapy on balance in children with hemiplegic cerebral palsy. Seventy child with hemiplegic cerebral were enrolled in this study and were assessed for eligibility. Their aged ranged from eight to twelve years. The children were assigned randomly into two equal groups. Group (a) control group received traditional physical therapy program. And group (b) study group received the same traditional physical therapy program in addition to mirror therapy three times / weak for three successful months. Biodex balance system was used to assess balance pre and post treatment. All children were assisted before and after three months of intervention.

Interventions

OTHERMIRROR THERAPY

The children were instructed to sitting on chair and a mirror is placed in midsagittal plane of the child, with the normal limb in front of mirror and the affected limb is blocked so the patient see only the reflected movement of the sound limb (non affected).

Sponsors

South Valley University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Masking description

Blinding process to participants and care providers was impossible due to the nature of intervention therapy. Data were analyzed by an impartial statistician (outcomes assessor), referring to each arm with an encoded name: Group A (control group) and Group B (study group).

Intervention model description

The children were assigned randomly into two equal groups. Group (a) control group received traditional physical therapy program. And group (b) study group received the same traditional physical therapy program in addition to mirror therapy three times / weak for three successful months.

Eligibility

Sex/Gender
ALL
Age
8 Years to 12 Years
Healthy volunteers
No

Inclusion criteria

* Children's aged ranged from eight to twelve years. * Children participated in this study will from both sexes. * Their degree of spasticity will ranged from mild to moderate according to Modified Ashworth Scale. * Children with stable medical and psychological status. * Children able to follow the verbal commands or instructions.

Exclusion criteria

* children with visual or auditory problems. * Children with history of epilepsy. * Children with history of surgical interference in lower limbs less than one year. * Medically unstable children especially with cardiovascular disorders. * Mentally retarded children. * un-cooperative children.

Design outcomes

Primary

MeasureTime frameDescription
Antro-posterior stability indexAntro-posterior stability index will be assessed at day 0.the ability of child to maintain his balance from forward to backward direction
Over All Stability IndexOver All Stability Index will be assessed at day 0.the ability of child to maintain his balance in all directions
Mediolateral Stability IndexMediolateral Stability Index will be assessed at day 0.the ability of child to maintain his balance from side to side directions

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026